These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 30554400)

  • 1. Fecal volatile organic compounds for early detection of colorectal cancer: where are we now?
    Bosch S; Berkhout DJ; Ben Larbi I; de Meij TG; de Boer NK
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):223-234. PubMed ID: 30554400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
    de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
    Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volatile organic compounds as new biomarkers for colorectal cancer: a review.
    Di Lena M; Porcelli F; Altomare DF
    Colorectal Dis; 2016 Jul; 18(7):654-63. PubMed ID: 26752703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
    van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
    Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary volatile organic compounds for colorectal cancer screening: A systematic review and meta-analysis.
    van Liere ELSA; van Dijk LJ; Bosch S; Vermeulen L; Heymans MW; Burchell GL; de Meij TGJ; Ramsoekh D; de Boer NKH
    Eur J Cancer; 2023 Jun; 186():69-82. PubMed ID: 37030079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel non-invasive colorectal cancer diagnostic method: Volatile organic compounds as biomarkers.
    Alustiza M; Ripoll L; Canals A; Murcia O; Martínez-Roca A; García-Heredia A; Giner-Calabuig M; Jover R; Vidal L
    Clin Chim Acta; 2023 Mar; 542():117273. PubMed ID: 36863694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer.
    Bond A; Greenwood R; Lewis S; Corfe B; Sarkar S; O'Toole P; Rooney P; Burkitt M; Hold G; Probert C
    Aliment Pharmacol Ther; 2019 Apr; 49(8):1005-1012. PubMed ID: 30828825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Fatty Acid Profiling as a Potential New Screening Biomarker in Patients with Colorectal Cancer.
    Song EM; Byeon JS; Lee SM; Yoo HJ; Kim SJ; Lee SH; Chang K; Hwang SW; Yang DH; Jeong JY
    Dig Dis Sci; 2018 May; 63(5):1229-1236. PubMed ID: 29516324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting Colorectal Adenomas and Cancer Using Volatile Organic Compounds in Exhaled Breath: A Proof-of-Principle Study to Improve Screening.
    Cheng HR; van Vorstenbosch RWR; Pachen DM; Meulen LWT; Straathof JWA; Dallinga JW; Jonkers DMAE; Masclee AAM; Schooten FV; Mujagic Z; Smolinska A
    Clin Transl Gastroenterol; 2022 Nov; 13(11):e00518. PubMed ID: 35981245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection and follow-up of colorectal neoplasia based on faecal volatile organic compounds.
    Bosch S; Bot R; Wicaksono A; Savelkoul E; van der Hulst R; Kuijvenhoven J; Stokkers P; Daulton E; Covington JA; de Meij TGJ; de Boer NKH
    Colorectal Dis; 2020 Sep; 22(9):1119-1129. PubMed ID: 32040880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
    Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
    Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The scent of colorectal cancer: detection by volatile organic compound analysis.
    de Boer NK; de Meij TG; Oort FA; Ben Larbi I; Mulder CJ; van Bodegraven AA; van der Schee MP
    Clin Gastroenterol Hepatol; 2014 Jul; 12(7):1085-9. PubMed ID: 24823289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer and adenoma screening using urinary volatile organic compound (VOC) detection: early results from a single-centre bowel screening population (UK BCSP).
    Mozdiak E; Wicaksono AN; Covington JA; Arasaradnam RP
    Tech Coloproctol; 2019 Apr; 23(4):343-351. PubMed ID: 30989415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for volatile biomarkers of colorectal cancer by analyzing breath and fecal samples using thermal desorption combined with GC-MS (TD-GC-MS).
    Śmiełowska M; Ligor T; Kupczyk W; Szeliga J; Jackowski M; Buszewski B
    J Breath Res; 2023 Jul; 17(4):. PubMed ID: 37406626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.
    Bosch LJW; de Wit M; Pham TV; Coupé VMH; Hiemstra AC; Piersma SR; Oudgenoeg G; Scheffer GL; Mongera S; Sive Droste JT; Oort FA; van Turenhout ST; Larbi IB; Louwagie J; van Criekinge W; van der Hulst RWM; Mulder CJJ; Carvalho B; Fijneman RJA; Jimenez CR; Meijer GA
    Ann Intern Med; 2017 Dec; 167(12):855-866. PubMed ID: 29159365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up.
    Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G
    Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosing gastrointestinal illnesses using fecal headspace volatile organic compounds.
    Chan DK; Leggett CL; Wang KK
    World J Gastroenterol; 2016 Jan; 22(4):1639-49. PubMed ID: 26819529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breath testing as potential colorectal cancer screening tool.
    Amal H; Leja M; Funka K; Lasina I; Skapars R; Sivins A; Ancans G; Kikuste I; Vanags A; Tolmanis I; Kirsners A; Kupcinskas L; Haick H
    Int J Cancer; 2016 Jan; 138(1):229-36. PubMed ID: 26212114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
    Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of volatile organic compounds in SW620 colorectal cancer cells and tumor-bearing mice.
    Wang G; Li Y; Liu M; Guo N; Han C; Liu D; Li D; Yang M; Peng Y; Liu Y; Yu K; Wang C
    J Pharm Biomed Anal; 2019 Apr; 167():30-37. PubMed ID: 30738241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.